NEW YORK – The World Health Organization on Monday released an update to its operational handbook on the diagnosis of tuberculosis that provides laboratory personnel, clinicians, ministries of health, ...

Last week, readers were most interested in a story about Diasorin's preparation to enter the point-of-care molecular testing space with a benchtop instrument.

China's volume-based procurement policy and US tariffs have forced companies with large businesses in China to reset their ...

Stakeholders suggested that while the FDA rule is dead, updates to LDT regulation are coming, nonetheless, and the industry ...

Danaher subsidiaries Beckman Coulter, Cepheid, and Leica Biosystems will be working together with external partners to focus ...

The development marks a shift up the value chain for labs and could prove a meaningful revenue stream for providers able to ...

The South Korean firm said that its CURECA system offers walkaway PCR testing with 24/7 operation without human intervention ...

The target device includes a portable instrument and 30-minute, $5 assays requiring only small volumes of whole capillary blood.

The test is compatible with lateral flow technology and could be used to provide tuberculosis testing in low-resource settings.

The firm's genomics revenues more than doubled year over year, while data and services revenue increased nearly 36 percent.

The laboratory medicine organization is focused on the benefits of using data science within laboratories to more effectively care for patients and track utilization.

The test simultaneously detects and differentiates between SARS-CoV-2, influenza A/B, and respiratory syncytial virus.